Clinical trial
Risedronate in Postmenopausal Women With Low Bone Density
NCT00351091 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00351091 |
|---|---|
| Title | Risedronate in Postmenopausal Women With Low Bone Density |
| Official title | a Six Month, Multicenter, Randomized, Double-blind, Active-controlled, Parallel Group Study to Estimate the Pharmacodynamic Response of Two Risedronate Regimens Compared With 5mg Daily : 150mg Monthly Dose for Six Months and 15mg Daily for Thirty Days Followed by 150mg Monthly Dose for 5 Months in… |
| Lead sponsor | Sanofi, Industry |
| Collaborators | Procter and Gamble Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | OSTEOPOROSIS, POSTMENOPAUSAL |
| Intervention type | Drug |
| Interventions | RISEDRONATE |
| Enrollment | 150 |
| Start date | Nov 1, 2002 |
| Primary completion | Jun 1, 2003 |
| Completion | Jun 1, 2003 |
| First posted | Jul 12, 2006 |
| Last update posted | Feb 17, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: